PGEN

#2176
Precigen, Inc. Common Stock
4.26 USD
+2.16%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
4.17
4.28
Range Annuel
1.22
5.47
Changement quotidien
+2.16%
Changement Mensuel
+20.00%
Evolution sur 6 mois
+32.30%
Changement Annuel
+202.13%
Clôture Précédente
4.17
Open
4.17
Bid
Ask
Low
4.17
High
4.28
Volume
117
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
  • Market Capitalization 1.51 B
  • Employee 47
  • Founded 1998
  • CEO Helen Sabzevari
  • Website www.precigen.com
  • Headquarter Virginia, United States
  • FIGI BBG000QL8VH9
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.05
Price to sales ratio
135.09

Precigen Inc

Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.

Nouvelles